5-134607045-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_016103.4(SAR1B):c.502C>T(p.Leu168Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000062 ( 0 hom. )
Consequence
SAR1B
NM_016103.4 synonymous
NM_016103.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.91
Genes affected
SAR1B (HGNC:10535): (secretion associated Ras related GTPase 1B) The protein encoded by this gene is a small GTPase that acts as a homodimer. The encoded protein is activated by the guanine nucleotide exchange factor PREB and is involved in protein transport from the endoplasmic reticulum to the Golgi. This protein is part of the COPII coat complex. Defects in this gene are a cause of chylomicron retention disease (CMRD), also known as Anderson disease (ANDD). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 5-134607045-G-A is Benign according to our data. Variant chr5-134607045-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1565655.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.91 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAR1B | NM_016103.4 | c.502C>T | p.Leu168Leu | synonymous_variant | Exon 7 of 7 | ENST00000402673.7 | NP_057187.1 | |
SAR1B | NM_001033503.3 | c.502C>T | p.Leu168Leu | synonymous_variant | Exon 8 of 8 | NP_001028675.1 | ||
SAR1B | XM_047417257.1 | c.502C>T | p.Leu168Leu | synonymous_variant | Exon 7 of 7 | XP_047273213.1 | ||
SAR1B | XM_047417258.1 | c.298C>T | p.Leu100Leu | synonymous_variant | Exon 5 of 5 | XP_047273214.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460932Hom.: 0 Cov.: 29 AF XY: 0.00000413 AC XY: 3AN XY: 726828 show subpopulations
GnomAD4 exome
AF:
AC:
9
AN:
1460932
Hom.:
Cov.:
29
AF XY:
AC XY:
3
AN XY:
726828
Gnomad4 AFR exome
AF:
AC:
0
AN:
33460
Gnomad4 AMR exome
AF:
AC:
0
AN:
44720
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26124
Gnomad4 EAS exome
AF:
AC:
0
AN:
39694
Gnomad4 SAS exome
AF:
AC:
0
AN:
86246
Gnomad4 FIN exome
AF:
AC:
0
AN:
53408
Gnomad4 NFE exome
AF:
AC:
8
AN:
1111154
Gnomad4 Remaining exome
AF:
AC:
0
AN:
60362
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
152140
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74326
Gnomad4 AFR
AF:
AC:
0.0000241383
AN:
0.0000241383
Gnomad4 AMR
AF:
AC:
0
AN:
0
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0
AN:
0
Gnomad4 OTH
AF:
AC:
0
AN:
0
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 03, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at